News und Analysen
Humana Takes Steps to Care for Members in Response to Coronavirus
Humana Inc. (NYSE: HUM) announced today several actions in response to the increased spread of the coronavirus (COVID-19).
“As we navigate the spread of the coronavirus, our top priority is the
Susan Hockfield Elected to Pfizer’s Board of Directors
Pfizer Inc. (NYSE: PFE) today announced the election of Dr. Susan Hockfield to its Board of Directors, effective immediately. Dr. Hockfield, age 68, was also appointed to the Regulatory and
Agilent Introduces Three New Microarrays for Prenatal and Postnatal Research
Agilent Technologies Inc. (NYSE: A) today introduced three new microarrays to meet the needs of cytogenetic laboratories conducting both prenatal and postnatal research.
The new Agilent
Agilent and Visiopharm Co-promote Advanced Digital Precision Pathology Solutions
Agilent Technologies Inc. (NYSE: A) and Visiopharm today announced that they have entered a co-marketing agreement. The announcement is happening at the USCAP 109th Annual Meeting being held
Waters Drives Materials Sciences Innovation Forward at Pittcon 2020 with New Instrument Introductions
Waters Corporation (NYSE:WAT) today introduced new products that bring greater productivity and efficiency to materials science research. The new Discovery™ X3 Differential Scanning Calorimeter
Agilent Technologies Announces Webcasts for Investment Community
Agilent Technologies Inc. (NYSE: A) today announced the following webcasts for the investment community.
40th Annual Cowen And Company Healthcare Conference
Tuesday, March 3, 2020 at 10:00 a.m
James Quincey Elected to Pfizer’s Board of Directors
Pfizer Inc. (NYSE: PFE) today announced the election of James Quincey to its Board of Directors, effective immediately. Mr. Quincey, age 55, was also appointed to the Compensation Committee and the
Illumina Files Additional Patent Infringement Suit Against BGI in the U.S.
Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed a patent infringement suit relating to BGI’s “CoolMPS” sequencing products. The complaint was filed against BGI Genomics Co., Ltd
Mylan and Pfizer Announce Appointment of Viatris Chief Financial Officer
Mylan N.V. (NASDAQ: MYL) and Pfizer (NYSE: PFE) today announced that Sanjeev Narula, current chief financial officer (CFO) of Upjohn, a division of Pfizer, has been named incoming CFO of Viatris
Mylan and Pfizer Finalize Appointments to Viatris Board of Directors
Mylan N.V. (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced the remaining appointees to the inaugural 13-member Board of Directors for Viatris, the new company that will result from the
Aledade and Humana Announce Broadened Collaboration, Signing Value-Based Agreement for Humana Medicare Members in North Carolina
Aledade, Inc. and leading health and well-being company Humana Inc. (NYSE: HUM) today announced an agreement to expand the availability of value-based care for Humana Medicare Advantage members in
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Pfizer Inc. (NYSE:PFE) invites investors and the general public to listen to a webcast of a discussion with Charles Triano, Senior Vice President, Investor Relations, at the Cowen and Company 40th
Agilent Technologies Reports First Quarter Fiscal Year 2020 Financial Results
Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.36 billion for the first quarter ended Jan. 31, 2020, up 5.7% year over year (and up 2.4% on a core(1) basis).
On a GAAP basis
European Commission Approves VYNDAQEL®, the First Treatment in the EU for Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has approved VYNDAQEL® (tafamidis), a once-daily 61 mg oral capsule, for the treatment of wild-type or hereditary
Illumina to Webcast Upcoming Investor Conference Presentations
Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conferences and invited investors to participate via webcast.
SVB Leerink Global
Agilent Technologies Announces Twist Bioscience Agrees to Pay $22.5 Million Settlement in IP Litigation
Agilent Technologies Inc. (NYSE: A) today announced it has reached an agreement with Twist Bioscience under which Twist has agreed to pay Agilent a sum of $22.5 million to settle Agilent’s claims
Dr. Scott Gottlieb, former US FDA Commissioner, joins Illumina’s Board of Directors
Illumina, Inc. (NASDAQ: ILMN) announced today that Scott Gottlieb, M.D. has joined the company’s Board of Directors, effective February 4, 2020. Dr. Gottlieb is currently a special partner at the
Problem Zivilisationskrankheiten? Eher nicht für Aktionäre von Edwards Lifesciences...
Pfizer Receives Positive CHMP Opinion for Oncology Biosimilar, RUXIENCE™ (rituximab)
Pfizer Inc. (NYSE: PFE) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending marketing
Agilent Teams with Indian Institute of Technology Delhi to Enhance Biotherapeutics
Agilent Technologies Inc. (NYSE: A) today announced that it is joining forces with the Indian Institute of Technology Delhi (IIT Delhi) to promote biopharmaceutical research.
Agilent and IIT
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2019
Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the fourth quarter and fiscal year 2019.
Fourth quarter 2019 results:
-
Revenue of $953 million, a 10% increase compared
Agilent Technologies to Webcast First Quarter Fiscal Year 2020 Financial Results Conference Call
Agilent Technologies, Inc. (NYSE: A) will release first-quarter fiscal year 2020 financial results after the stock market closes on Feb. 18. The company will also host a live webcast of its
PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2019 RESULTS
Pfizer Inc. (NYSE: PFE) reported financial results for fourth-quarter and full-year 2019 and provided 2020 financial guidance.
Results for the fourth quarter and the full year of 2019 and 2018(7)
Agilent Introduces New Cutting-Edge SureSelect DNA Kit
Agilent Technologies Inc. (NYSE: A) today introduced a new product designed to address key challenges that laboratories encounter when preparing DNA sequencing libraries for their research. The new
Humana Foundation Investing $7.6 Million in Eight Communities to Address Social Determinants of Health
The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM) for the past 38 years, is investing $7.6 million in eight communities across the southeastern United States to address social